Remove partner-contents
article thumbnail

How can marketing teams and healthcare agencies partner up for modular content?

pharmaphorum

Creating personalised, compliant content is becoming increasingly important for life science companies as HCPs demand more from their digital content. times more digital content than print in 2020, driven by the growing prevalence of digital channels during the early stages of the Covid-19 pandemic. Pharma companies created 3.5

article thumbnail

Ginkgo Bioworks partners with WARF for new GD2 CAR T-cell therapies

Pharmaceutical Technology

Ginkgo will partner with researchers from Wisconsin-Madison to discover new and improved GD2 CAR designs with improved persistence, fitness and proliferation. The company can use its mammalian cell engineering expertise and capabilities to screen CAR T-cells, to discover and optimise next-generation therapeutic candidates for its partners.

In-Vivo 264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Myeloid raises funds to support lead cell therapy programme

Pharmaceutical Technology

Led by Hatteras Investment Partners, the financing round has seen participation from existing investors, including 8VC, Alexandria Venture Investments and Newpath Partners, along with new investors Moore Strategic Ventures and ARCH Venture Partners. Topic sponsors are not involved in the creation of editorial content.

In-Vivo 246
article thumbnail

August 1, 2023: NIH Collaboratory Expands LinkedIn Presence to Join Growing Community of Researchers

Rethinking Clinical Trials

If you are active on LinkedIn, we invite you to follow our page for the latest news about our innovative Demonstration Projects, tools and resources from the Core Working Groups, upcoming sessions of our weekly Rethinking Clinical Trials Grand Rounds webinar series, and fresh content from the Living Textbook of Pragmatic Clinical Trials.

article thumbnail

GreenLight and US NIH partner to develop Covid-19 vaccine for variants

Pharmaceutical Technology

GreenLight Biosciences Human Health chief science officer Amin Khan said: “This is a tremendous opportunity for us to partner with a premier vaccine discovery team and use our mRNA platform to accelerate the development of coronavirus vaccines which are more broadly protective and durable than those currently available.”.

article thumbnail

GenScript ProBio and RVAC partner for Covid-19 vaccine pDNA

Pharmaceutical Technology

To support the mRNA initiatives, RVAC Medicines will continue to partner with GenScript ProBio for the clinical-stage development and commercial stage of its candidates. Editorial content is independently produced and follows the highest standards of journalistic integrity.

article thumbnail

April 4, 2023: New Quick Start Guide Pulls Together Resources for ePCT Project Managers

Rethinking Clinical Trials

The guides serve as annotated tables of contents, pointing readers to essential content in the Living Textbook to help successfully launch an ePCT and partner with healthcare systems leaders. The Quick Start Guide for Investigators is designed for clinical investigators interested in learning how to conduct an ePCT.